Search results for "Cg"

showing 10 items of 999 documents

Semipredictable dynamical systems

2015

A new class of deterministic dynamical systems, termed semipredictable dynamical systems, is presented. The spatiotemporal evolution of these systems have both predictable and unpredictable traits, as found in natural complex systems. We prove a general result: The dynamics of any deterministic nonlinear cellular automaton (CA) with $p$ possible dynamical states can be decomposed at each instant of time in a superposition of $N$ layers involving $p_{0}$, $p_{1}$,... $p_{N-1}$ dynamical states each, where the $p_{k\in \mathbb{N}}$, $k \in [0, N-1]$ are divisors of $p$. If the divisors coincide with the prime factors of $p$ this decomposition is unique. Conversely, we also prove that $N$ CA w…

Numerical AnalysisDynamical systems theoryCellular Automata and Lattice Gases (nlin.CG)Applied MathematicsComplex systemFOS: Physical sciencesMathematical Physics (math-ph)Nonlinear Sciences - Chaotic Dynamics01 natural sciencesCellular automaton010305 fluids & plasmasCombinatoricsNonlinear systemSuperposition principleModeling and Simulation0103 physical sciencesPrime factorChaotic Dynamics (nlin.CD)Moufang loop010306 general physicsNonlinear Sciences - Cellular Automata and Lattice GasesMathematical PhysicsMathematicsCommunications in Nonlinear Science and Numerical Simulation
researchProduct

Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a …

2014

Contains fulltext : 153742.pdf (Publisher’s version ) (Closed access) BACKGROUND: The impact of prognostic factors in T1G3 non-muscle-invasive bladder cancer (BCa) patients is critical for proper treatment decision making. OBJECTIVE: To assess prognostic factors in patients who received bacillus Calmette-Guerin (BCG) as initial intravesical treatment of T1G3 tumors and to identify a subgroup of high-risk patients who should be considered for more aggressive treatment. DESIGN, SETTING, AND PARTICIPANTS: Individual patient data were collected for 2451 T1G3 patients from 23 centers who received BCG between 1990 and 2011. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Using Cox multivariable re…

OncologyMaleNon–muscle-invasive bladderBacillus Calmette-Guerin; BCG; Non-muscle-invasive bladder cancer; Prognostic factors; T1G3Settore MED/24 - UrologiaRisk groupsRetrospective StudieRisk FactorsBCGAge Factorskin and connective tissue diseasesBacillus Calmette-GuerinBacillus (shape)Prognostic factorbiologyBacillus Calmette-Gue´rin BCG Non–muscle-invasive bladder cancer Prognostic factors T1G3Age FactorsBacillus Calmette-Gue´rinMiddle AgedPrognosisTumor BurdenBacilluSurvival RateUrological cancers Radboud Institute for Health Sciences [Radboudumc 15]Urinary Bladder NeoplasmBCG VaccineDisease ProgressionFemaleNon muscle invasiveCalmette-GuérinCarcinoma in SituHumanmedicine.medical_specialtyPrognosiNon-muscle-invasive bladder cancerUrologyUrologyT1G3Prognostic factorsCystectomyRisk AssessmentNon–muscle-invasive bladder cancerFollow-Up StudieAdjuvants ImmunologicInternal medicineUrological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15]medicinecancerHumansAgedRetrospective StudiesBladder cancerbusiness.industryRisk Factorbiology.organism_classificationmedicine.diseaseMulticenter studyUrinary Bladder NeoplasmsProper treatmentNeoplasm Recurrence LocalbusinessFollow-Up StudiesEuropean urology
researchProduct

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy includi…

2015

Part of this study has been reported as an oral presentation at the EHA Meeting in Vienna 2015.

OncologyMalemedicine.medical_treatmentarray-based comparative genomic hybridization (aCGH)Intensive chemotherapyKaplan-Meier EstimateBioinformatics0302 clinical medicinerituximabAntineoplastic Combined Chemotherapy ProtocolsYoung adultComparative Genomic HybridizationGenomeArray-based comparative genomic hybridizationBurkitt lymphomaHigh-Throughput Nucleotide SequencingHematologyMiddle AgedPrognosisBurkitt Lymphomahumanities3. Good healthTreatment Outcome030220 oncology & carcinogenesisoutcomeRituximabFemaleRituximabmedicine.drugAdultmedicine.medical_specialtyAdolescenteducationBiologyNext-generation sequencing outcome03 medical and health sciencesYoung AdultInternal medicinemedicineHumansIn patientAgedChromosome AberrationsChemotherapymedicine.diseaseGNA13Lymphomastomatognathic diseasesnext-generation sequencing030215 immunologyComparative genomic hybridization
researchProduct

G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group,…

2020

IntroductionAmyotrophic lateral sclerosis (ALS) is a fatal progressive neurological disorder characterised by a selective degeneration of motor neurons (MNs). Stem cell transplantation is considered as a promising strategy in neurological disorders therapy and the possibility of inducing bone marrow cells (BMCs) to circulate in the peripheral blood is suggested to investigate stem cells migration in degenerated ALS nerve tissues where potentially repair MN damage. Granulocyte-colony stimulating factor (G-CSF) is a growth factor which stimulates haematopoietic progenitor cells, mobilises BMCs into injured brain and it is itself a neurotrophic factor for MN. G-CSF safety in humans has been de…

Oncologyamyotrophic lateral sclerosismedicine.medical_specialtyFilgrastimFilgrastimPlacebocGSF ALS Clinical triallaw.inventionrandomised clinical trialClinical Trials Phase II as TopicDouble-Blind MethodRandomized controlled triallawInternal medicinemedicineHumansMulticenter Studies as Topic1506Amyotrophic lateral sclerosisRandomized Controlled Trials as Topicbusiness.industryRGeneral Medicineamyotrophic lateral sclerosis; GCS-F; haematopoietic stem cells; randomised clinical trialmedicine.diseaseGranulocyte colony-stimulating factorTransplantationClinical trialGCS-FNeurologyItalyTolerabilityQuality of Life1713MedicineSettore MED/26 - Neurologiabusinesshaematopoietic stem cellsmedicine.drugBMJ Open
researchProduct

[Endovesical treatment as an alternative to BCG for intermediate or high-risk NMI bladder cancer].

2012

A shortage of BCG is foreseen till the end of 2013. Which will be the management of intermediate and high-risk NMI-BC if BCG will not be available? In patients harboring high-risk NMI tumors, particularly T1G3 and Tis, the first therapeutic choice is radical cystectomy. Device-assisted therapies, although showing promising results, should be considered only for selected patients. In intermediate risk patients, intravesical chemotherapy remains a legitimate option even if BCG is available. Thus, in a period of BCG shortage, intravesical chemotherapy should be offered, preferably preceded by early instillation, according to the EAU guidelines.

Oncologymedicine.medical_specialtyBladder cancerbusiness.industryEconomic shortageAntineoplastic AgentsGeneral Medicinemedicine.diseaseRisk AssessmentAdministration IntravesicalAdjuvants ImmunologicUrinary Bladder NeoplasmsInternal medicineBCG VaccineMedicineHumansIn patientNeoplasm InvasivenessbusinessNeoplasm StagingUrologia
researchProduct

A first comparative map of copy number variations in the sheep genome.

2011

article i nfo We carried out a cross species cattle-sheep array comparative genome hybridization experiment to identify copy number variations (CNVs) in the sheep genome analysing ewes of Italian dairy or dual-purpose breeds (Bagnolese, Comisana, Laticauda, Massese, Sarda, and Valle del Belice) using a tiling oligonucleotide array with ~385,000 probes designed on the bovine genome. We identified 135 CNV regions (CNVRs; 24 reported in more than one animal) covering ~10.5 Mb of the virtual sheep genome referred to the bovine genome (0.398%) with a mean and a median equal to 77.6 and 55.9 kb, respectively. A comparative analysis between the identified sheep CNVRs and those reported in cattle a…

Ovis ariesDNA Copy Number VariationsRuminantSheep breedsaCGH; Comparative map; Copy number variation; Ovis aries; Ruminants; Sheep breedsGenomicsOvis arieBiologyGenomeChromosomesSettore AGR/17 - Zootecnica Generale E Miglioramento Genetico03 medical and health sciencesaCGHChromosome regionsGeneticsAnimalsCopy-number variationGene030304 developmental biologyOligonucleotide Array Sequence AnalysisGeneticsCOMPARATIVE MAPPING0303 health sciencesComparative Genomic HybridizationGenomeSheepCopy number variation0402 animal and dairy scienceComparative Genome HybridizationChromosome Mapping04 agricultural and veterinary sciencesRuminantsbiology.organism_classification040201 dairy & animal scienceBovine genomeSardaCattleComparative mapGenomics
researchProduct

Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis.

2020

Abstract Background Throughout the 5000-year history of China, more than 300 epidemics were recorded. Traditional Chinese herbal medicine (TCM) has been used effectively to combat each of these epidemics’ infections, and saved many lives. To date, there are hundreds of herbal TCM formulae developed for the purpose of prevention and treatment during epidemic infections. When COVID-19 ravaged the Wuhan district in China in early January 2020, without a deep understanding about the nature of COVID-19, patients admitted to the TCM Hospital in Wuhan were immediately treated with TCM and reported later with >90% efficacy. Approach We conducted conduct a systematic survey of various TCM herbal pre…

PTGS2 Prostaglandin-endoperoxide synthase 2BattleAIV avian influenza virusCoV coronavirusPharmaceutical ScienceiNOS nitric oxide synthaseViral infection0302 clinical medicinePA patchouli alcoholSARS Severe Acute Respiratory SyndromeSMD Sheganmahuang decoctionDrug DiscoveryPandemicIL InterleukinMedicine Chinese TraditionalALI acute lung injuriesmedia_commonCOVID-19 coronavirus disease 2019MXSG Ma xing shi gan decoction0303 health sciencesTNF tumor necrosis factorClinical Trials as TopicCCL2 CC chemokine ligand 2FM1 FM1 coronavirusICU intensive care unitc-AMP cyclic adenosine phosphateHIV human immunodeficiency virus030220 oncology & carcinogenesisCOX-2 cyclooxygenase-2Molecular MedicineHerbal preparationsMedicinal herbsAbbreviations: ACE2 angiotensin-converting enzyme IITCM traditional Chinese medicineHSV-1 herpes simplex virus 1CASP3 caspase 3medicine.medical_specialtyChinaCoronavirus disease 2019 (COVID-19)Systematic surveymedia_common.quotation_subjectJEV Japanese encephalitis virusNF-κB nuclear factor kappa B cellsAntiviral AgentsArticleWHO World Health Organization03 medical and health sciencesIEC-6 rat intestinal epithelial cell line 6SOD superoxide dismutaseCDC Center for Disease Control and PreventionmedicineAVP arginine vasopressinPGE2 prostaglandin E2HumansIntensive care medicineLH Lianhuaqingwen capsule030304 developmental biologyPharmacologyMedicinal herbMDA malondialdehydeGCGJ Gancao ganjiang decoctionNO nitric oxidePlants Medicinalbusiness.industrySARS-CoV-2COVID-19CXCL C-X-C- motif chemokineMDCK Madin-Darby Canine Kidney cellsTLR-4 Toll-like receptor-4COVID-19 Drug TreatmentComplementary and alternative medicineViral infectionLPS lipopolysaccharidesRSV respiratory syncytial virusQFPD Qingfeipaidu decoctionbusinessLung congestionECMO extracorporeal membrane oxygenationMAPK mitogen-activated protein kinasePhytotherapyDrugs Chinese HerbalPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

A new breath of life for anoxia.

2008

The middle of the Cretaceous (120–80 Ma) was one of the warmest periods of the past 300 m.y., with tropical sea-surface temperatures well over 30 °C ([Puceat et al., 2007][1]; [Forster et al., 2007a][2]) and atmospheric CO2 levels much higher than today. Therefore this period can give us crucial

Paleontology[ SDE.MCG ] Environmental Sciences/Global ChangesOceanography[ SDU.STU.OC ] Sciences of the Universe [physics]/Earth Sciences/OceanographyPeriod (geology)Geology[ SDU.STU.GC ] Sciences of the Universe [physics]/Earth Sciences/GeochemistryCretaceousGeologyComputingMilieux_MISCELLANEOUS[ SDU.STU.PG ] Sciences of the Universe [physics]/Earth Sciences/Paleontology
researchProduct

Initial conditions in AA and pA collisions

2016

A full understanding of the spacetime evolution of the QCD matter created in a heavy ion collision requires understanding the properties of the initial stages. In the weak coupling picture these are dominated by classical gluon fields, whose properties can also be studied via the scattering of dilute probes off a high energy hadron or nucleus. A particular challenge is understanding small systems, where LHC data is also showing signs of collective behavior. We discuss some recent results of on the initial matter production and thermalization in heavy ion collisions, in particular in the gluon saturation framework.

Particle physicsCollective behaviorNuclear TheoryQC1-999HadronFOS: Physical sciencesGLUON PRODUCTION114 Physical sciences01 natural sciencesNuclear Theory (nucl-th)High Energy Physics - Phenomenology (hep-ph)quantum chromodynamics0103 physical sciencesNuclear Experiment010306 general physicsPLUS PB COLLISIONSNUCLEUSQCD matterPhysicsgluon fieldsLarge Hadron Colliderta114010308 nuclear & particles physicsScatteringPhysicsCGC PREDICTIONSHigh Energy Physics::PhenomenologyTRANSVERSE-MOMENTUMCOLOR GLASS CONDENSATEFIELDSEVOLUTIONGluonheavy ion collisionHigh Energy Physics - PhenomenologyCoupling (physics)ThermalisationLHCgluon saturationEPJ Web of Conferences
researchProduct

Inflammation in the Human Periodontium Induces Downregulation of the α1- and β1-Subunits of the sGC in Cementoclasts

2021

Nitric oxide (NO) binds to soluble guanylyl cyclase (sGC), activates it in a reduced oxidized heme iron state, and generates cyclic Guanosine Monophosphate (cGMP), which results in vasodilatation and inhibition of osteoclast activity. In inflammation, sGC is oxidized and becomes insensitive to NO. NO- and heme-independent activation of sGC requires protein expression of the &alpha

Periodontium0301 basic medicinealveolar bonecementoclastslcsh:Chemistrychemistry.chemical_compound0302 clinical medicineCathepsin Kheterocyclic compoundsperiodontitisCyclic GMPlcsh:QH301-705.5SpectroscopyGeneral MedicineComputer Science ApplicationsResorptionCell biologymedicine.anatomical_structurecardiovascular systemOxidation-Reductioncementuminorganic chemicalsPeriodontal LigamentIronAntigens Differentiation MyelomonocyticHemeArticleCatalysisNitric oxideInorganic Chemistry03 medical and health sciencesstomatognathic systemAntigens CDnitric oxideOsteoclastmedicineAnimalsHumansddc:610CementumPhysical and Theoretical ChemistryMolecular BiologyCyclic guanosine monophosphateInflammationOrganic Chemistrysoluble guanylyl cyclase030206 dentistryPeriodontiumcGMPosteoclasts030104 developmental biologyGene Expression Regulationlcsh:Biology (General)lcsh:QD1-999chemistrySoluble guanylyl cyclaseInternational Journal of Molecular Sciences
researchProduct